HMGB3: High Mobility Group Box 3 – Chromatin Regulator and Cancer-Associated Gene

Comprehensive genomic and proteomic overview of HMGB3, a member of the HMG-box family involved in transcription, DNA repair, and oncogenesis.

Gene Information Card

Symbol HMGB3
Full Name High Mobility Group Box 3
Gene Type Protein coding
Chromosomal Location Xq28
NCBI Gene ID 3149 ncbi.nlm.nih.gov/gene/3149
Ensembl ID ENSG00000129988
UniProt ID O15347
OMIM ID 300193
HGNC ID 5004
Aliases HMG2A, HMG-2a, HMG2, HMG-2

Description

HMGB3 (High Mobility Group Box 3) encodes a member of the high mobility group (HMG) box family of non-histone chromatin proteins. The protein contains two HMG box domains that bind DNA with low sequence specificity but high structural affinity, particularly to distorted or bent DNA structures. HMGB3 functions as an architectural chromatin factor that facilitates nucleosome remodeling, transcription factor assembly, and DNA repair. It is highly expressed during embryonic development and in certain adult tissues, and its dysregulation is implicated in several cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer HMGB3 overexpression promotes proliferation and metastasis via NF-κB and Wnt/β-catenin signaling PMID: 25944712
Lung Cancer Upregulation of HMGB3 enhances cell migration and invasion through EMT induction PMID: 29393451
Gastric Cancer HMGB3 acts as an oncogene by activating PI3K/Akt pathway and inhibiting apoptosis PMID: 27683189
Colorectal Cancer HMGB3 overexpression correlates with poor prognosis and promotes tumor growth PMID: 30323318
Hepatocellular Carcinoma HMGB3 silencing reduces cell viability and induces G1 arrest PMID: 31065072

Expression Profile

Tissue Expression
Tissue nTPM level
Bone Marrow 12.5 Medium
Lymph Node 8.3 Low
Spleen 7.1 Low
Testis 6.8 Low
Brain 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical cancer cell line
A549 11.4 Lung cancer cell line
MCF7 9.8 Breast cancer cell line
HepG2 8.5 Liver cancer cell line
K562 7.3 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Likely loss of start codon; predicted loss of function
c.214C>T (p.Arg72Trp) Missense <0.1% Unknown significance; rare population variant
c.403G>A (p.Glu135Lys) Missense <0.1% Reported in COSMIC; potential gain-of-function in cancer
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in HMGB3; homozygous knockout in mice is lethal.

Gain of Function (GOF)

Overexpression and copy number gains are observed in multiple cancers, suggesting oncogenic gain-of-function.

Dominant Negative (DN)

No dominant-negative mutations have been described for HMGB3.

Pathways

• Wnt signaling pathway (Reactome: R-HSA-195721)
• NF-κB signaling (Reactome: R-HSA-975138)
• PI3K/Akt signaling (Reactome: R-HSA-1257604)
• Epithelial-to-mesenchymal transition (Reactome: R-HSA-6798695)

Protein Summary

HMGB3 is a 200-amino-acid protein (23 kDa) belonging to the HMG-box family. It contains two tandem HMG boxes (box A and box B) and a C-terminal acidic tail. The protein binds to the minor groove of DNA, inducing bends and facilitating the assembly of higher-order nucleoprotein complexes. HMGB3 shuttles between the nucleus and cytoplasm, and its post-translational modifications (e.g., acetylation, phosphorylation) regulate its DNA-binding affinity and cellular localization. It is essential for embryonic development and stem cell maintenance, and its overexpression in cancer correlates with poor prognosis.

Related Products

Product name Cat.No. Species Gene ID
HMGB3 Knockout HEK293 Cell Line EDJ-KQ50351 Human 3149 Details Get a Quote
HMGB3 Knockout HeLa Cell Line EDJ-KQ53530 Human 3149 Details Get a Quote
HMGB3 Knockout A-549 Cell Line EDJ-KQ62003 Human 3149 Details Get a Quote
HMGB3 Knockout HCT 116 Cell Line EDJ-KQ70480 Human 3149 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: